BWXT
BWX Technologies, Inc.
$134.24
-1.17% 2026-10-20
IndustrialsS&P 400
BWXTSPY
1W
-3.3%
1M
-9.0%
3M
-22.3%
6M
-37.9%
YTD
-22.0%
1Y
-35.0%
Live chart
Loading live chart…
Grades vs sector
Momentum8th pct in sectorF
Momentum
8th pct in sector
12-1 return: -35.5%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
Growth77th pct in sectorB+
Growth
77th pct in sector
Revenue growth (YoY): +18.0%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
Value11th pct in sectorD-
Value
11th pct in sector
Forward E/P: 3.8% · EBITDA/EV: 3.4%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
Profitability69th pct in sectorB
Profitability
69th pct in sector
Profit margin: +10.1% · Return on equity: +28.3%
Percentile within its GICS sector across the S&P 1500.
Percentile within its GICS sector across the S&P 1500.
RevisionsNot enough data yet–
Revisions
Not enough data yet
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
30-day change in analysts' current-year EPS estimate; graded across covered stocks.
Our models
Not held by any of our 5 live models right now.
Quality Growth
not ranked (outside this model's universe or screens)
Momentum Top 15not ranked (outside this model's universe or screens)
Momentum Blendnot in the current book
New Highs Growthnot ranked (outside this model's universe or screens)
Conviction 20not in the current book
News
More news3 Stocks Set to Benefit From Long-Term AI Tailwinds
Zacks · 22h ago
Should This One Number Scare You About NuScale Power Stock?
Trefis · Oct 13
Key stats
Market cap$12.3B
P/E (trailing)34.8
P/E (forward)25.6
52-week range131.60 – 241.82
Revenue growth (YoY, latest qtr)+18.0%
Dividend yield0.78%
Analyst consensusBuy (16)
Mean price target$209.44 (+56%)
Valuation and fundamentals
Valuation & fundamentals
Bottom line
Roughly fairly valued
Model read-out from the numbers below, not advice. Score +0 (DCF counts double).
•DCF (base case)below the price by 10%
▼Forward P/E vs sector25.6x vs median 17.1x
•Piotroski F-score5/9
▲Altman Z4.6 (safe)
•Net debt / EBITDA2.6x
▲Analyst target+56% (16 analysts)
Discounted cash flow
Bear
$61
-55%
growth 9% · disc. 8.9% · term. 2.0%
Base
$120
-10%
growth 15% · disc. 7.9% · term. 2.5%
Bull
$217
+61%
growth 19% · disc. 6.9% · term. 3.0%
A DCF starts from trailing free cash flow, so it can overstate value if the last 12 months were unusually strong (or weak). Use the bear case or edit the starting cash flow if so.
Reverse DCFfor context, not a signal
A normal DCF guesses future cash flows and works out a price. A reverse DCF runs it backwards: it starts from today's price and asks how fast free cash flow would have to grow to justify it. It tells you what the market is assuming, not whether the stock is cheap or expensive, and it is not a buy or sell signal. Glossary
Today's price assumes free cash flow grows about 13% a year for 10 years.
Implied
+13%/yr
FCF, last 3 yrs
+85%/yr
FCF, last 5 yrs
n/a
Revenue, last 3 yrs
+13%/yr
Revenue, last 5 yrs
+9%/yr
Same inputs as the DCF above: trailing free cash flow 0.3B, 7.9% discount rate, 2.5% growth after year 10, net debt and today's share count. Actual growth rates are compound annual rates from SEC annual filings through FY2025; "n/a" means too little history or a negative starting year.
Edit assumptions · recalculates instantly
Your value per share–
Free cash flow = operating cash flow − capital spending, trailing 12 months (TTM to 2026-06-30). Growth default: average of 3-year revenue CAGR and latest revenue growth, capped at 30%. Years 6–10 fade linearly to terminal growth. Discount rate = 4.25% risk-free assumption + beta 0.74 × 5% equity premium, kept within 7–13%. Bear: lower growth, +1 pt discount, 2% terminal. Bull: higher growth, −1 pt, 3%.
Multiples vs Industrials
P/E (trailing)
pricier
sector median 26.4× · 73rd pct
34.8×pricier
Forward P/E
pricier
sector median 17.1× · 84th pct
25.6×pricier
EV / EBITDA
pricier
sector median 14.8× · 89th pct
25.2×pricier
Price / sales
pricier
sector median 2.1× · 72nd pct
3.5×pricier
Price / book
pricier
sector median 3.5× · 86th pct
9.2×pricier
FCF yield
pricier
sector median 4.5% · 22nd pct
2.6%pricier
Forward EPS $5.23 vs trailing $3.86 (+36% expected growth). Forward P/E uses analysts' next-12-month estimate.
Backlog (remaining performance obligations)
RPO
$8.4B
as of 2026-06-30
vs a year ago
+40%
YoY
× TTM revenue
2.39×
coverage
Contracted revenue not yet recognized, from SEC filings (XBRL tag RevenueRemainingPerformanceObligation).
Quality & financial health
Gross margin
–
Operating margin
12.1%
FCF margin
9.0%
Net margin
10.1%
Return on equity
26.6%
Return on invested capital
12.9%
Net debt / EBITDA
2.6×
Current ratio
2.4×
Interest cover
12.4×
Cash conversion (OCF/NI)
1.5×
Piotroski F-score 5/9 · last two fiscal years
✓ Positive net income✓ Positive operating cash flow✗ Return on assets improved✓ Cash flow above net income✗ Long-term debt / assets fell✓ Current ratio improved✓ No share dilution✗ Gross margin improved✗ Asset turnover improved
Altman Z-score 4.6 (safe zone; above 3.0 = safe, below 1.8 = distress). Not meaningful for banks and insurers.
Analysts
Mean target
$209
+56%
Analysts
16
Buy
Range
$150–$290
low – high
● price · ◆ mean target
Annual history
| FY | Revenue | Net income | Free cash flow |
|---|---|---|---|
| 2025 | $3.2B | $328.9M | $295.3M |
| 2024 | $2.7B | $281.9M | $254.8M |
| 2023 | $2.5B | $245.8M | $212.4M |
| 2022 | $2.2B | $238.2M | $46.4M |
| 2021 | $2.1B | $305.9M | $75.0M |
| 2020 | $2.1B | $278.7M | $-58.6M |
From the company's 10-K filings via SEC XBRL. 3-year revenue CAGR +12.7%.
Earnings
Next report: 2026-11-02 · during market · EPS est 1.19
EstimateActual (beat)Actual (miss)
| Report | EPS est | Actual | Surprise |
|---|---|---|---|
| 2026-08-03 | 1.04 | 1.07 | +2.7% |
| 2026-05-04 | 0.93 | 1.12 | +21.0% |
| 2026-02-23 | 0.88 | 1.08 | +22.2% |
| 2025-11-03 | 0.87 | 1.00 | +14.3% |
| 2025-08-04 | 0.79 | 1.02 | +28.7% |
| 2025-05-05 | 0.76 | 0.91 | +19.0% |
| 2025-02-24 | 0.82 | 0.92 | +12.6% |
| 2024-11-04 | 0.77 | 0.83 | +7.1% |
Quarterly revenue
| Quarter | Revenue | YoY |
|---|---|---|
| 2026-06-30 | $901.6M | +18.0% |
| 2026-03-31 | $860.2M | – |
| 2025-12-31 | $885.8M | – |
| 2025-09-30 | $866.3M | – |
| 2025-06-30 | $764.0M | – |
Analyst actions
JP Morgan
PT $190
2026-10-13 · main
Overweight → OverweightPT $190
Truist Securities
PT $182
2026-10-06 · main
Hold → HoldPT $182
Northland Capital Markets
PT $220
2026-09-30 · main
Outperform → OutperformPT $220
B of A Securities
PT $210
2026-09-30 · main
Buy → BuyPT $210
Guggenheim
PT $192
2026-09-30 · reit
Buy → BuyPT $192
BTIG
PT $235
2026-09-30 · reit
Buy → BuyPT $235
Recent dividends
2026-08-18: $0.270 · 2026-05-19: $0.270 · 2026-03-11: $0.270 · 2025-11-19: $0.250 · 2025-08-18: $0.250 · 2025-05-19: $0.250 · 2025-03-11: $0.250 · 2024-11-19: $0.240
Insider trades
Geveden Rex D
$412.1K
Director, President and CEO · 2026-08-12
SELL$412.1K
Geveden Rex D
$814.4K
Director, President and CEO · 2026-08-12
SELL$814.4K
Geveden Rex D
$45.5K
Director, President and CEO · 2026-08-12
SELL$45.5K
Geveden Rex D
$453.0K
Director, President and CEO · 2026-08-12
SELL$453.0K
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
None
–
None · None
SELL–
Stats refreshed 2026-10-20 18:13:34 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now
coteau
Coteau Systematic Strategies publishes stock research and model portfolios. It doesn't manage money or give investment advice. Results are hypothetical unless marked Live. Data: Yahoo Finance (delayed) and SEC EDGAR.